These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19745660)

  • 1. Valproic acid toxicity associated with low dose of aspirin and low total valproic acid levels: a case report.
    de Leon J; Kiesel JL; Fleming MW; Strobl B
    J Clin Psychopharmacol; 2009 Oct; 29(5):509-11. PubMed ID: 19745660
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
    Lunde JL; Nelson RE; Storandt HF
    Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizures from valproate-carbapenem interaction.
    Taha FA; Hammond DN; Sheth RD
    Pediatr Neurol; 2013 Oct; 49(4):279-81. PubMed ID: 23932807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions.
    Sandson NB; Marcucci C; Bourke DL; Smith-Lamacchia R
    Am J Psychiatry; 2006 Nov; 163(11):1891-6. PubMed ID: 17074939
    [No Abstract]   [Full Text] [Related]  

  • 5. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
    Fudio S; Carcas A; Piñana E; Ortega R
    J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between plasma levels of valproic acid alone and its efficacy and toxicity in pediatric patients under chronic treatment].
    Armijo JA; Valiente R; Herranz JL
    Arch Farmacol Toxicol; 1981 Apr; 7(1):49-56. PubMed ID: 6798945
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reye syndrome treated with valproic acid in association with varicella infection].
    Lorz U; Glötzner FL
    Nervenarzt; 1989 May; 60(5):291-3. PubMed ID: 2500610
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproic acid and ethosuximide interaction.
    Mattson RH; Cramer JA
    Ann Neurol; 1980 Jun; 7(6):583-4. PubMed ID: 6776874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
    Gu J; Huang Y
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly.
    Felix S; Sproule BA; Hardy BG; Naranjo CA
    J Clin Psychopharmacol; 2003 Oct; 23(5):471-8. PubMed ID: 14520124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy with carbamazepine and valproic acid in problem cases at an outpatient epilepsy clinic].
    Fröscher W; Stoll KD; Hoffmann F
    Arzneimittelforschung; 1984; 34(8):910-4. PubMed ID: 6437416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patients.
    Pugh CB; Garnett WR; Poynor WJ; Pellock JM
    Clin Pharm; 1984; 3(6):643-9. PubMed ID: 6439455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.
    Bug G; Ritter M; Wassmann B; Schoch C; Heinzel T; Schwarz K; Romanski A; Kramer OH; Kampfmann M; Hoelzer D; Neubauer A; Ruthardt M; Ottmann OG
    Cancer; 2005 Dec; 104(12):2717-25. PubMed ID: 16294345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of valproate toxicity related to isoniazid.
    Stewart JT; Nesmith MW; Mattox KM
    J Clin Psychopharmacol; 2012 Dec; 32(6):840-1. PubMed ID: 23131873
    [No Abstract]   [Full Text] [Related]  

  • 19. Valproic acid.
    Sharma M; Agrawal P
    Indian Pediatr; 1991 Aug; 28(8):921-6. PubMed ID: 1808081
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mitochondrial diseases due to drug toxicity].
    Yamanouchi H; Imataka G
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():473-7. PubMed ID: 12013917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.